Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.
about
Antiglucocorticoid and related treatments for psychosisAntiglucocorticoid and related treatments for psychosisCelecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsMethodological Issues in Cytokine Measurement in SchizophreniaInflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical ImplicationsMeta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effectsTranscriptome sequencing of the choroid plexus in schizophreniaMolecular substrates of schizophrenia: homeostatic signaling to connectivityTraditional knowledge and formulations of medicinal plants used by the traditional medical practitioners of bangladesh to treat schizophrenia like psychosis.Biomarker Development for Brain-Based Disorders: Recent Progress in PsychiatryThe mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders.Efficacy of an Extract of Ocimum tenuiflorum (OciBest) in the Management of General Stress: A Double-Blind, Placebo-Controlled Study.Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis.Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis.Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in miceHPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis.Clozapine and risperidone influence on cortisol and estradiol levels in male patients with schizophrenia.Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatmentAssociation between Serum Cortisol and DHEA-S Levels and Response to Antipsychotic Treatment in SchizophreniaProteomic profiling in schizophrenia: enabling stratification for more effective treatment.Factors associated with response to clozapine in schizophrenia: a review.Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia.Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids.A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality.Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies.Blood test for schizophrenia.The biochemical womb of schizophrenia: A review.The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients.Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects.Role of cortisol in patients at risk for psychosis mental state and psychopathological correlates: A systematic review.Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes.Difference in inflammatory cytokine production by mononuclear cells from obese and non-obese schizophrenic patients.Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidineSchizotypal personality in healthy adults is related to blunted cortisol responses to the combined dexamethasone/ corticotropin-releasing hormone test.Using Functional Analysis as a Framework to Guide Individualized Treatment for Negative Symptoms.Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.Increased high-sensitivity C-reactive protein levels in Taiwanese schizophrenic patients.
P2860
Q24186594-4BE10D27-61EA-4FD6-9E7E-1E7268DDBD72Q24243495-7239FF19-D971-4CE3-9C31-21C11788C55CQ26741541-40C531EB-FAC2-4A18-9295-1372B55C9D3DQ26751839-98498784-4967-488D-988B-AFEADF6232DBQ28066646-D7B1053F-9583-47F8-BEAB-6720BCE1A077Q28657600-8DD90569-CF8A-47E4-8732-0E68F3D694E6Q30363952-EA6C3419-C06E-4430-9949-15DA0CBFAEE6Q30383611-15C35441-5ECF-4415-A480-AFD8A01BEB01Q33908361-6CD96F1F-A540-43E4-A2E2-35A4315D03E4Q34010400-A0CDB6E5-93EC-45D6-924D-DCE64B71D1A1Q34088944-2C4F8413-706E-4900-BAC6-9E935336B375Q34183522-2A113AF6-CE1F-444E-838E-2C2D40259773Q34214660-22273099-0BB0-4028-AB42-EEFF5560419FQ35257260-DF7C2A34-120A-4722-A226-AFD2FA6CAF88Q35757725-93077853-36BF-4B78-B157-9D18F60AFA0BQ35768164-C2074A52-4389-4B30-917C-BE703F39B558Q35950801-C9D72F0F-4F7A-4970-B05D-A61012AAAD45Q35982317-D38C6256-AA57-4135-B628-F6309462D99FQ36296028-E09A67EC-54A0-43AF-AC06-AC134E69E46BQ36310008-B685F98F-8BD1-4C04-8827-D58DDDBD9865Q36442033-A924B492-2231-43CA-BADA-3C14CD385FD0Q36929049-007C507C-9807-4AA2-A7EA-51462320301BQ36998471-1CAC3496-03C5-402E-9FCB-97EE13F88FEDQ37300007-E3EB8845-2541-492F-AEFE-2CFAC437392FQ37479996-5DA25968-57D9-4133-942E-1A0CBC735678Q37631141-C3E45A3F-5B04-4840-8D8B-8DC9C5D2E749Q37798087-B46D4D88-1F04-4B3D-B171-DA56742438F8Q37820728-5EC10FA4-29AB-477A-AD1C-B95D5D35DADCQ38038106-00588A19-84A7-4E00-A642-D77A72F9A996Q38056122-DBAC92D9-380B-4F4B-A9B9-3EECFC339C75Q38170139-7EB8406D-558A-4789-B700-904060FEB5C7Q38203227-F4D740F5-78F8-432E-BD4C-4D1400F40860Q38272093-B0D6FAD2-BF56-466A-B301-993A5560DA63Q39064271-15803ED6-B40F-4D42-84B6-CE25BE0296FCQ41518498-FA16C028-ADC1-498B-8197-1D4E75463BD8Q42375259-2850397A-9456-4201-846B-1BDD9F2970EEQ42597589-299B2229-E44C-4CDD-84AF-DACE4FF097CAQ47104736-D0217949-F504-4833-A843-7C060F6789B5Q47582903-4CB6B157-288F-41F5-B861-1E2D3D17D4F3Q48000662-55400C8F-6285-4047-B71C-B74272A8B4A1
P2860
Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cortisol and cytokines in chro ...... nd response to antipsychotics.
@ast
Cortisol and cytokines in chro ...... nd response to antipsychotics.
@en
type
label
Cortisol and cytokines in chro ...... nd response to antipsychotics.
@ast
Cortisol and cytokines in chro ...... nd response to antipsychotics.
@en
prefLabel
Cortisol and cytokines in chro ...... nd response to antipsychotics.
@ast
Cortisol and cytokines in chro ...... nd response to antipsychotics.
@en
P2093
P2860
P356
P1476
Cortisol and cytokines in chro ...... nd response to antipsychotics.
@en
P2093
Dong Feng Zhou
Gui Ying Wu
Lian Yuan Cao
Xiang Yang Zhang
Yu Cun Shen
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300756
P407
P577
2005-08-01T00:00:00Z
P5875
P6179
1036662857